Narcolepsy Therapeutics Market size, trends, opportunities and Forecast to 2032
According to a survey conducted in 2021 in the U.S., the top unmet needs cited by patients and healthcare professionals (HCPs) include the requirement for non-scheduled therapeutic options or no/low abuse drug potential, more tolerable drug regime, a more effective and novel mechanism of action beyond presently available therapies, and reduced dose medications. In addition, the disorder profoundly increases the psychosocial burden on people with narcolepsy.